Concepedia

Tim Liebner

TL

Statistics

Publications

5

Citations

415

H-Index

5

Active since

2021

Affiliations

Novo Nordisk Foundation(Current)

University of Copenhagen

Tim Liebner is an author at Novo Nordisk Foundation specializing in life sciences, molecular biology, and transcriptional regulation.

ORCID

Publications per year

2021–2024

5

Publications

5

Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release

Takeo Narita, Shinsuke Ito, Yoshiki Higashijima et al. · Molecular Cell · 2021 · 235 citations · Full text

, , +10

Acetylation of histone H2B marks active enhancers and predicts CBP/p300 target genes

Takeo Narita, Yoshiki Higashijima, Sinan Kilic et al. · Nature Genetics · 2023 · 88 citations · Full text

, , +17

HDAC6 modulates myofibril stiffness and diastolic function of the heart

Ying‐Hsi Lin, Jennifer L. Major, Tim Liebner et al. · Journal of Clinical Investigation · 2022 · 51 citations · Full text

, , +15

Acetylation of histones and non-histone proteins is not a mere consequence of ongoing transcription

Tim Liebner, Sinan Kilic, Jonas Walter et al. · Nature Communications · 2024 · 26 citations · Full text

, , +11

A unique H2B acetylation signature marks active enhancers and predicts their target genes

Takeo Narita, Yoshiki Higashijima, Sinan Kilic et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2022 · 15 citations · Full text

, , +17

1–5 of 5